LITTLE FALLS, N.J.--(BUSINESS WIRE)--Sentrx, the leading provider of pharmacovigilance services to the life sciences industry, is pleased to announce the appointment of Michael Mickens as VP, Commercial Development. A 20 year veteran, Michael has been actively engaged in helping clients adopt and adapt to technologies and services including electronic data capture, interactive voice response, electronic patient diaries, as well as technology-driven risk management services and analytical tools used in managing drug safety. His expertise blending clinically oriented technology and services into solutions for biopharmaceutical organizations of all stages of development brings a broad array of experience to the Sentrx client base.
